Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.81 18.23% 0.13
MCRB closed up 18.23 percent on Wednesday, November 20, 2024, on 3.13 times normal volume. It ran into resistance at its 50 day moving average.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Lower Bollinger Band Walk Weakness 18.23%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 19 hours ago
Rose Above Upper Bollinger Band about 19 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Rose Above 50 DMA about 20 hours ago
Possible Pocket Pivot about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seres Therapeutics, Inc. Description

Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Autoimmune Disease Clinical Development Antibiotics Inflammatory Bowel Disease Ulcerative Colitis Ulcer Colitis Diarrhea Digestive Diseases Antimicrobial Resistance Cdi Clostridioides Difficile Clostridium Difficile Infection Clostridium Difficile

Is MCRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.05
52 Week Low 0.54
Average Volume 3,899,530
200-Day Moving Average 0.90
50-Day Moving Average 0.83
20-Day Moving Average 0.71
10-Day Moving Average 0.66
Average True Range 0.08
RSI (14) 57.08
ADX 16.3
+DI 32.81
-DI 18.39
Chandelier Exit (Long, 3 ATRs) 0.64
Chandelier Exit (Short, 3 ATRs) 0.79
Upper Bollinger Bands 0.88
Lower Bollinger Band 0.55
Percent B (%b) 0.8
BandWidth 46.91
MACD Line -0.04
MACD Signal Line -0.05
MACD Histogram 0.0071
Fundamentals Value
Market Cap 105.2 Million
Num Shares 129 Million
EPS -1.11
Price-to-Earnings (P/E) Ratio -0.73
Price-to-Sales 1.16
Price-to-Book 63.84
PEG Ratio -0.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.13
Resistance 3 (R3) 1.12 1.00 1.08
Resistance 2 (R2) 1.00 0.92 1.01 1.06
Resistance 1 (R1) 0.91 0.87 0.96 0.92 1.05
Pivot Point 0.79 0.79 0.81 0.80 0.79
Support 1 (S1) 0.69 0.71 0.74 0.71 0.58
Support 2 (S2) 0.58 0.66 0.58 0.56
Support 3 (S3) 0.48 0.58 0.55
Support 4 (S4) 0.49